Profund Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.32M Sell
4,446
-251
-5% -$81.2K 0.05% 270
2025
Q4
$1.43M Sell
4,697
-1,134
-19% -$371K 0.04% 271
2025
Q3
$1.99M Buy
5,831
+1,091
+23% +$331K 0.06% 193
2025
Q2
$1.15M Sell
4,740
-455
-9% -$112K 0.04% 271
2025
Q1
$1.41M Buy
5,195
+609
+13% +$142K 0.06% 228
2024
Q4
$847K Buy
4,586
+170
+4% +$34.7K 0.03% 331
2024
Q3
$991K Sell
4,416
-364
-8% -$65.5K 0.04% 326
2024
Q2
$682K Sell
4,780
-1,181
-20% -$182K 0.03% 404
2024
Q1
$932K Sell
5,961
-464
-7% -$74.7K 0.04% 374
2023
Q4
$1.16M Buy
6,425
+1,268
+25% +$229K 0.05% 299
2023
Q3
$928K Buy
5,157
+695
+16% +$138K 0.05% 303
2023
Q2
$796K Sell
4,462
-661
-13% -$152K 0.04% 379
2023
Q1
$1.1M Sell
5,123
-164
-3% -$39.3K 0.07% 278
2022
Q4
$1.16M Sell
5,287
-4,294
-45% -$787K 0.08% 238
2022
Q3
$1.29M Buy
9,581
+519
+6% +$89.1K 0.09% 191
2022
Q2
$1.47M Buy
9,062
+535
+6% +$83.6K 0.09% 189
2022
Q1
$1.61M Buy
8,527
+3,349
+65% +$712K 0.07% 228
2021
Q4
$1.4M Sell
5,178
-3,584
-41% -$1.21M 0.05% 254
2021
Q3
$3.18M Buy
8,762
+41
+0.5% +$13.4K 0.11% 158
2021
Q2
$2.99M Sell
8,721
-101
-1% -$33.5K 0.1% 166
2021
Q1
$3.07M Buy
8,822
+1,011
+13% +$335K 0.12% 146
2020
Q4
$2.02M Buy
7,811
+2,674
+52% +$736K 0.09% 195
2020
Q3
$1.47M Buy
5,137
+934
+22% +$220K 0.08% 212
2020
Q2
$792K Sell
4,203
-325
-7% -$52.9K 0.04% 304
2020
Q1
$557K Sell
4,528
-2,649
-37% -$414K 0.04% 339
2019
Q4
$1.19M Buy
7,177
+1,382
+24% +$230K 0.05% 311
2019
Q3
$710K Sell
5,795
-1,402
-19% -$186K 0.04% 445
2019
Q2
$892K Sell
7,197
-2,414
-25% -$306K 0.04% 404
2019
Q1
$1.27M Buy
9,611
+2,858
+42% +$386K 0.06% 286
2018
Q4
$947K Sell
6,753
-3,689
-35% -$489K 0.06% 284
2018
Q3
$1.8M Sell
10,442
-1,618
-13% -$272K 0.07% 228
2018
Q2
$1.85M Sell
12,060
-2,518
-17% -$449K 0.07% 219
2018
Q1
$2.45M Sell
14,578
-1,245
-8% -$169K 0.1% 166
2017
Q4
$1.55M Buy
15,823
+10,213
+182% +$935K 0.06% 302
2017
Q3
$580K Buy
5,610
+98
+2% +$7.3K 0.02% 684
2017
Q2
$248K Buy
+5,512
New +$217K 0.01% 1220

Other funds holding ONC